Literature DB >> 18358369

Does highly cross-linked polyethylene wear less than conventional polyethylene in total hip arthroplasty? A double-blind, randomized, and controlled trial using roentgen stereophotogrammetric analysis.

Sion Glyn-Jones1, Sherif Isaac, Jennifer Hauptfleisch, Peter McLardy-Smith, David W Murray, Harinderjit Singh Gill.   

Abstract

A prospective double-blind, randomized, and controlled trial was conducted using roentgen stereophotogrammetric analysis; 54 total hip arthroplasty patients were randomized to receive either highly cross-linked polyethylene (HXLPE) or standard ultra-high-molecular-weight polyethylene (UHMWPE) liners. The 3-dimensional penetration of the liner was determined over 2 years. For the first 3 months, both polyethylene types had a rapid penetration rate (HXLPE: 0.22 mm, SD = 0.17 mm; UHMWPE: 0.21 mm, SD = 0.15 mm; P = .78). After 3 months, the HXLPE penetration rate (0.06 mm/y, SD = 0.06 mm/y) was significantly lower than the UHMWPE penetration rate (0.10 mm/y, SD = 0.07 mm/y; P = .04). The penetration in the first 3 months was probably caused by creep or bedding in; from 3 months onward, much of the penetration was probably caused by wear. We conclude that HXLPE has a 40% lower wear rate as compared with UHMWPE, suggesting that it will perform better in the long term.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358369     DOI: 10.1016/j.arth.2006.12.117

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  27 in total

1.  Continued improved wear with an annealed highly cross-linked polyethylene.

Authors:  William N Capello; James A D'Antonio; Rama Ramakrishnan; Marybeth Naughton
Journal:  Clin Orthop Relat Res       Date:  2010-09-16       Impact factor: 4.176

2.  The incidence of acetabular osteolysis in young patients with conventional versus highly crosslinked polyethylene.

Authors:  Nathan A Mall; Ryan M Nunley; Jin Jun Zhu; William J Maloney; Robert L Barrack; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

Review 3.  Total elbow arthroplasty is moving forward: Review on past, present and future.

Authors:  Ante Prkić; Christiaan Ja van Bergen; Bertram The; Denise Eygendaal
Journal:  World J Orthop       Date:  2016-01-18

4.  Wear is reduced in THA performed with highly cross-linked polyethylene.

Authors:  Burak Beksaç; Antonio Salas; Alejandro González Della Valle; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-12-12       Impact factor: 4.176

5.  Correlation of computed tomography with histology in the assessment of periprosthetic defect healing.

Authors:  Stephen D Cook; Laura P Patron; Samantha L Salkeld; Kirk E Smith; Bruce Whiting; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

6.  High stress conditions do not increase wear of thin highly crosslinked UHMWPE.

Authors:  Natalie H Kelly; Amar D Rajadhyaksha; Timothy M Wright; Suzanne A Maher; Geoffrey H Westrich
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

7.  Role of polyethylene particles in peri-prosthetic osteolysis: A review.

Authors:  Gerald J Atkins; David R Haynes; Donald W Howie; David M Findlay
Journal:  World J Orthop       Date:  2011-10-18

8.  The John Charnley Award: Highly crosslinked polyethylene in total hip arthroplasty decreases long-term wear: a double-blind randomized trial.

Authors:  Siôn Glyn-Jones; Geraint E R Thomas; Patrick Garfjeld-Roberts; Roger Gundle; Adrian Taylor; Peter McLardy-Smith; David W Murray
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

9.  Polyethylene oxidation in total hip arthroplasty: evolution and new advances.

Authors:  Enrique Gómez-Barrena; Francisco Medel; José Antonio Puértolas
Journal:  Open Orthop J       Date:  2009-12-24

10.  UHMWPE for arthroplasty: past or future?

Authors:  Elena Maria Brach Del Prever; Alessandro Bistolfi; Pierangiola Bracco; Luigi Costa
Journal:  J Orthop Traumatol       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.